At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 40 enrolled
Drug / intervention
Dexlansoprazoledrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Single-Center, Open-Label, 2-Arm Parallel Group, Single-Dose Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 mg and 60 mg Delayed-Release Capsules in Healthy Chinese Subjects
In Brief
A Phase 1 clinical trial evaluating Dexlansoprazole for Healthy Volunteers. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the pharmacokinetics after a single dose of dexlansoprazole 30 and 60 mg delayed-release capsules in healthy Chinese participants.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesChina
Collaborators--
Timeline
Phase 1CompletedFinished
201820192020202120222023202420252026
First PostedOct 2017
Enrollment StartNov 2017
Primary CompletionFeb 2018
TodayJul 2026
First PostedOct 23, 2017
Enrollment StartNov 22, 2017
Primary CompletionFeb 8, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 8.7 years ago
Interventions
Dexlansoprazoledrug
Dexlansoprazole delayed-release capsule.